{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:33:13Z","timestamp":1760783593392},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T00:00:00Z","timestamp":1340064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"abstract":"<jats:p>A retrospective study analyzing patient medical records examined the effect of transarterial chemoembolization on hepatitis C virus viremia in patients with hepatitis C virus\u2013associated hepatocellular carcinoma. Transarterial chemoembolization did not lead to a substantial increase in hepatitis C virus viral load.<\/jats:p>","DOI":"10.1634\/theoncologist.2012-0187","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T15:38:44Z","timestamp":1348241924000},"page":"e21-e23","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Transcatheter Arterial Chemoembolization on Hepatitis C Viremia"],"prefix":"10.1093","volume":"17","author":[{"given":"Parag","family":"Mahale","sequence":"first","affiliation":[{"name":"a Departments of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Kaseb","sequence":"additional","affiliation":[{"name":"b Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Davila","sequence":"additional","affiliation":[{"name":"c Departments of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrys A.","family":"Torres","sequence":"additional","affiliation":[{"name":"c Departments of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,6,19]]},"reference":[{"key":"2021122308125809300_B1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1634\/theoncologist.2011-0313","article-title":"Transarterial chemoembolization plus sorafenib: A sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: A randomized clinical trial","volume":"17","author":"Sansonno","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308125809300_B2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrclinonc.2012.1","article-title":"Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer","volume":"9","author":"Torres","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"2021122308125809300_B3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(96)90212-3","article-title":"Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus","volume":"347","author":"Vento","year":"1996","journal-title":"Lancet"},{"key":"2021122308125809300_B4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2004.05.014","article-title":"Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma","volume":"41","author":"Jang","year":"2004","journal-title":"J Hepatol"},{"key":"2021122308125809300_B5","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/j.1572-0241.2005.00232.x","article-title":"Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: Report of a prospective study","volume":"100","author":"Park","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2021122308125809300_B6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/0003-4819-138-8-200304150-00036","article-title":"Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"138","author":"Vizzini","year":"2003","journal-title":"Ann Intern Med"},{"key":"2021122308125809300_B7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/PPO.0b013e3181d7e905","article-title":"Chemoembolization for primary and metastatic liver cancer","volume":"16","author":"Liapi","year":"2010","journal-title":"Cancer J"},{"key":"2021122308125809300_B8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/605561","article-title":"Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria","volume":"49","author":"McGovern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021122308125809300_B9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1001-9294(11)60041-2","article-title":"Serum HIF-1\u03b1 and VEGF levels pre- and post-TACE in patients with primary liver cancer","volume":"26","author":"Jia","year":"2011","journal-title":"Chin Med Sci J"},{"key":"2021122308125809300_B10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhep.2011.11.018","article-title":"A dual role for hypoxia inducible factor-1\u03b1 in the hepatitis C virus lifecycle and hepatoma migration","volume":"56","author":"Wilson","year":"2012","journal-title":"J Hepatol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2012-0187","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0187","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/17\/9\/e21\/41858337\/oncolo_17_9_e21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/17\/9\/e21\/41858337\/oncolo_17_9_e21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T20:09:39Z","timestamp":1640290179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/17\/9\/e21\/6401523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,19]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,6,19]]},"published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0187","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,9,1]]},"published":{"date-parts":[[2012,6,19]]}}}